Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EXACT Therapeutics AS ( (DE:56F) ) just unveiled an update.
EXACT Therapeutics AS announced that during their upcoming Annual General Meeting, separate votes will be conducted for each board of directors candidate. This decision allows shareholders to submit proxies or advance votes through the VPS or specified forms, ensuring a more tailored voting process. This move could potentially impact the company’s governance and strategic direction by allowing more precise shareholder input.
More about EXACT Therapeutics AS
EXACT Therapeutics is a clinical-stage precision medicine company that focuses on utilizing ultrasound and microbubbles for targeted drug delivery in oncology. Their proprietary Acoustic Cluster Therapy (ACT®) is designed to enhance the delivery of therapeutic agents across various medical conditions, including cancer and brain diseases. The company is publicly traded on Euronext Growth Oslo under the ticker EXTX.
Average Trading Volume: 17,239
Current Market Cap: NOK182.2M
See more insights into 56F stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue